Atlas Trials

CEST- Glucose Enhanced MRI for Metastatic Brain Tumours

Clinical trial NCT02796729 · TERMINATED

Trial details

NCT number
NCT02796729
Sponsor
British Columbia Cancer Agency
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Brain Neoplasms, MalignantMetastasis
Start date
2016-10-01
Primary completion
2018-12-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.